Literature DB >> 28854366

The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology.

Jui-Heng Tseng1, Ling Xie2, Sheng Song3, Youmei Xie4, Lauren Allen4, Deepa Ajit1, Jau-Shyong Hong3, Xian Chen2, Rick B Meeker4, Todd J Cohen5.   

Abstract

The initiating events that promote tau mislocalization and pathology in Alzheimer's disease (AD) are not well defined, partly because of the lack of endogenous models that recapitulate tau dysfunction. We exposed wild-type neurons to a neuroinflammatory trigger and examined the effect on endogenous tau. We found that tau re-localized and accumulated within pathological neuritic foci, or beads, comprised of mostly hypo-phosphorylated, acetylated, and oligomeric tau. These structures were detected in aged wild-type mice and were enhanced in response to neuroinflammation in vivo, highlighting a previously undescribed endogenous age-related tau pathology. Strikingly, deletion or inhibition of the cytoplasmic shuttling factor HDAC6 suppressed neuritic tau bead formation in neurons and mice. Using mass spectrometry-based profiling, we identified a single neuroinflammatory factor, the metalloproteinase MMP-9, as a mediator of neuritic tau beading. Thus, our study uncovers a link between neuroinflammation and neuritic tau beading as a potential early-stage pathogenic mechanism in AD.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; deacetylase; excitotoxic; neuroinflammatory; tau

Mesh:

Substances:

Year:  2017        PMID: 28854366      PMCID: PMC5578720          DOI: 10.1016/j.celrep.2017.07.082

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.995


  70 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

2.  Imaging amyloid precursor protein in vivo: an axonal transport assay.

Authors:  Tomás L Falzone; Gorazd B Stokin
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2012-01-20       Impact factor: 5.330

4.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Jose Sarmiento; Juan Troncoso; George R Jackson; Rakez Kayed
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

5.  Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease.

Authors:  Changiz Geula; Nicholas Nagykery; Alexander Nicholas; Chuang-Kuo Wu
Journal:  J Neuropathol Exp Neurol       Date:  2008-04       Impact factor: 3.685

6.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

7.  Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease.

Authors:  Erik Stomrud; Maria Björkqvist; Sabina Janciauskiene; Lennart Minthon; Oskar Hansson
Journal:  Alzheimers Res Ther       Date:  2010-06-24       Impact factor: 6.982

8.  Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model.

Authors:  Katherine A Hosie; Anna E King; Catherine A Blizzard; James C Vickers; Tracey C Dickson
Journal:  ASN Neuro       Date:  2012-02-23       Impact factor: 4.146

Review 9.  Retrograde Axonal Degeneration in Parkinson Disease.

Authors:  Patricia Tagliaferro; Robert E Burke
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

10.  Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.

Authors:  Ksenia Kurbatskaya; Emma C Phillips; Cara L Croft; Giacomo Dentoni; Martina M Hughes; Matthew A Wade; Safa Al-Sarraj; Claire Troakes; Michael J O'Neill; Beatriz G Perez-Nievas; Diane P Hanger; Wendy Noble
Journal:  Acta Neuropathol Commun       Date:  2016-03-31       Impact factor: 7.801

View more
  27 in total

1.  The Roles of Microtubules and Membrane Tension in Axonal Beading, Retraction, and Atrophy.

Authors:  Anagha Datar; Jaishabanu Ameeramja; Alka Bhat; Roli Srivastava; Ashish Mishra; Roberto Bernal; Jacques Prost; Andrew Callan-Jones; Pramod A Pullarkat
Journal:  Biophys J       Date:  2019-08-02       Impact factor: 4.033

2.  Gedunin Inhibits Oligomeric Aβ1-42-Induced Microglia Activation Via Modulation of Nrf2-NF-κB Signaling.

Authors:  Sara Tom; Anand Rane; Aditya S Katewa; Manish Chamoli; Rae R Matsumoto; Julie K Andersen; Shankar J Chinta
Journal:  Mol Neurobiol       Date:  2019-05-24       Impact factor: 5.590

3.  Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6.

Authors:  Jeremy D Osko; David W Christianson
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-08-19       Impact factor: 1.056

Review 4.  The complexity of tau in Alzheimer's disease.

Authors:  Nima N Naseri; Hong Wang; Jennifer Guo; Manu Sharma; Wenjie Luo
Journal:  Neurosci Lett       Date:  2019-04-25       Impact factor: 3.046

Review 5.  The tubulin code and its role in controlling microtubule properties and functions.

Authors:  Carsten Janke; Maria M Magiera
Journal:  Nat Rev Mol Cell Biol       Date:  2020-02-27       Impact factor: 94.444

6.  Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment.

Authors:  Angie C A Chiang; Xiaojiao Huo; Annemieke Kavelaars; Cobi J Heijnen
Journal:  Brain Behav Immun       Date:  2019-04-03       Impact factor: 7.217

7.  A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.

Authors:  Deepa Ajit; Hanna Trzeciakiewicz; Jui-Heng Tseng; Connor M Wander; Youjun Chen; Aditi Ajit; Diamond P King; Todd J Cohen
Journal:  J Biol Chem       Date:  2019-09-22       Impact factor: 5.157

8.  Tau seeds are subject to aberrant modifications resulting in distinct signatures.

Authors:  Jui-Heng Tseng; Aditi Ajit; Zarin Tabassum; Niyati Patel; Xu Tian; Youjun Chen; Alex W Prevatte; Karen Ling; Frank Rigo; Rick B Meeker; Laura E Herring; Todd J Cohen
Journal:  Cell Rep       Date:  2021-04-27       Impact factor: 9.423

9.  Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31.

Authors:  Jonathan E Fogle; Lola Hudson; Andrea Thomson; Barbara Sherman; Margaret Gruen; B Duncan Lacelles; Brenda M Colby; Gillian Clary; Frank Longo; Rick B Meeker
Journal:  J Neurovirol       Date:  2021-03-04       Impact factor: 3.739

10.  Small molecule modulation of the p75 neurotrophin receptor suppresses age- and genotype-associated neurodegeneration in HIV gp120 transgenic mice.

Authors:  Youmie Xie; Jaimie Seawell; Emily Boesch; Lauren Allen; Ashley Suchy; Frank M Longo; Rick B Meeker
Journal:  Exp Neurol       Date:  2020-09-29       Impact factor: 5.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.